Litalsa, Erle Robotics and Histocell: Basque companies that have received rounds in the Basque Country

03/07/2015
Diego Gutiérrez
Litalsa, Erle Robotics and Histocell: Basque companies that have received rounds in the Basque Country
In May, several Basque companies from different sectors received funding. Erle Robotics, a drone company, received €200,000 from 6 business angels. Histocell, located in Zamudio, has received €2.5 M to launch its new product and Realza has bought Litalsa, a leading independent supplier in the packaging lithography market.

 

Erle Robotics raises 200,000 euros in its funding round

The Alavesa drone company Erle Robotics, which stands out for its devices, developed with free software and hardware, has received a €200,000 funding round in which 6 business angels have participated, two Basque and four British.

 The company will use the funds to position its technology as a global pioneer and project its business internationally as it has just opened an office in Germany to strengthen its close relationship with the multinational. Bosch. Thanks to this foray into Germany, Erle Robotics has been selected by the German startup accelerator TechFounders to boost your business and develop new software for your device Erle Brain with new capabilities and sensors to enable new uses and applications.

"In addition, Elre Robotics intends to close another, larger round of financing in the second half of the year. Growth in this sector is essential to be able to compete. In Spain alone, the number of drone companies registered with AENA (Spanish airports and air navigation) has grown by 70 % so far in 2015. In addition, numerous internal companies have received million-dollar rounds in 2015, such as RD Robotics, which closed a $14M round in April" says Diego Gutierrez from Abra-Invest.

 Biopharmaceutical company Histocell receives round of funding

Biopharmaceuticals Histocell, located in the technology park of Zamudio, has closed a round 2.5m to bring its Reoxcare healing product to market, which is expected to be launched by the end of 2015. 

For the time being, the company has already reached agreements for the marketing of Reoxcare in different European and Asian markets, such as the one signed with the company Luqa Pharma for China, Hong Kong and Macao.

Histocell develops and commercialises medical devices and cell therapy medicines in the field of human health. In addition to the international launch of Reoxcare, the company plans to complete the development of three medical devices and to finalise the clinical phases I/IIa of two cell-based medicines in the five-year period 2015-2020.

 Realza buys Litalsa

Enhance Capital has bought a majority stake in the Basque company LitalsaAC Development, a leading independent supplier of lithography for packaging and mechanical closures, was in the hands of AC Development.

"For AC Desarrollo, the sale of Realza represents the first divestment of its AC Capital Premier II fund," says Diego Gutiérrez of AC Capital Premier II. Abra-Invest.

The purchase has been financed not only with equity but also with bank debt provided by Caixabank, Bankinter and Mutua.

With this investment, Realza expects to consolidate Litalsa's leadership in Spain and foster its international growth, accompanying existing customers.

 

If you are looking for financing in Abra -invest we can help you. Get in touch with us on +34.946024142

Other posts that may interest you

 biotech grows and finds alternative forms of finance

New funds for ICTs, Bio and internalisation (May)

Lastest news

The State of Technology M&A in Spain | October 2026 analysis

En octubre de 2026 hubo 37 operaciones de M&A tecnológico en España: 16 fueron adquisiciones corporativas, inversiones de private equity, fusiones o tomas de participación, y 21 fueron rondas de venture capital. El 62,2% de las operaciones (23 de 37) fueron...

Webinar | How much does your business depend on you?

IMPORTANT INFORMATION: Registration for and participation in the webinars are completely anonymous to third parties. If, for a month, you were unable to have a say in important decisions, what would happen in your company? Your company can grow, be profitable and have good...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?